Activist 13D/13G Filings - IBERE PHARMACEUTICALS (IBERU)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-14
12:36 pm
Purchase
13GIBERE PHARMACEUTICALS SHS
IBER
GLAZER CAPITAL LLC1,331,102
9.65%
1,331,102increase
(New Position)
View
2023-02-14
08:14 am
Sale
13GIBERE PHARMACEUTICALS SHS
IBER
CITADEL ADVISORS LLC4,057
0%
-775,377decrease
(-99.48%)
View
2023-02-08
3:19 pm
Purchase
13GIBERE PHARMACEUTICALS SHS
IBER
Hudson Bay Capital Management LP716,613
5.19%
716,613increase
(New Position)
View
2023-02-08
2:09 pm
Sale
13GIBERE PHARMACEUTICALS UNIT 1 C
IBERU
Hartree Partners LP0
0%
-1,285,000decrease
(Position Closed)
View
2023-02-02
11:10 am
Sale
13GIBERE PHARMACEUTICALS SHS
IBER
Magnetar Financial LLC785,872
5.69%
-7,419decrease
(-0.94%)
View
2022-02-14
06:12 am
Purchase
13GIBERE PHARMACEUTICALS SHS
IBER
CITADEL ADVISORS LLC779,434
5.6%
779,434increase
(New Position)
View
2022-02-08
4:23 pm
Purchase
13GIBERE PHARMACEUTICALS SHS
IBER
PIPV Capital LLC3,450,000
20%
3,450,000increase
(New Position)
View
2022-01-14
1:43 pm
Purchase
13GIBERE PHARMACEUTICALS SHS
IBER
Magnetar Financial LLC793,291
5.75%
793,291increase
(New Position)
View
2021-09-27
2:36 pm
Purchase
13GIBERE PHARMACEUTICALS UNIT 1 C
IBERU
Hartree Partners LP1,285,000
9.3%
1,285,000increase
(New Position)
View
2021-03-12
4:02 pm
Purchase
13GIBERE PHARMACEUTICALS UNIT 1 C
IBERU
CITADEL ADVISORS LLC776,710
5.6%
776,710increase
(New Position)
View